Brookfield Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,798	Closed	-$1.63M	–	172
2023 Q2	$1.63M	Sell	18,798 -118,545	-86%	-$11.2M	0.01%	424
2023 Q1	$13.4M	Sell	137,343 -38,302	-22%	-$3.97M	0.05%	136
2022 Q4	$18.2M	Buy	175,645 +29,330	+20%	+$2.75M	0.07%	100
2022 Q3	$12.4M	Sell	146,315 -12,541	-8%	-$1.12M	0.05%	139
2022 Q2	$13.2M	Sell	158,856 -31,272	-16%	-$2.49M	0.06%	117
2022 Q1	$14.7M	Buy	190,128 +95,426	+101%	+$7.98M	0.06%	118
2021 Q4	$8.37M	Buy	94,702 +26,930	+40%	+$2.22M	0.03%	147
2021 Q3	$5.24M	Sell	67,772 -14,255	-17%	-$1.12M	0.02%	214
2021 Q2	$6.84M	Buy	82,027 +10,839	+15%	+$859K	0.03%	174
2021 Q1	$5.38M	Buy	71,188 +18,281	+35%	+$1.49M	0.03%	157
2020 Q4	$4.64M	Buy	+52,907	New	+$4.19M	0.02%	170